Currently Enrolling Studies:
Four Repeat Tauopathy Neuroimaging Initiative (4RTNI-2)
- This study is investigating the best method of analysis to track patients with corticobasal syndrome, corticobasal degeneration, progressive supranuclear palsy, and oligo- or variant-progressive supranuclear palsy. The results will provide information about the value of novel imaging techniques for diagnosis and value of novel imaging techniques in comparison to biofluid biomarkers.
- The data collected from healthy volunteers will be used to understand how CBS, CBD, PSP and o/vPSP progress in comparison to healthy aging.
- The study will collect detailed clinical information, biofluids, and imaging data from individuals with corticobasal degeneration and progressive supranuclear palsy. There will be one visit every six months for a year (a total of three visits over one year). Oligo- or variant- progressive supranuclear palsy, and healthy participants will be asked for an additional visit approximately one year after the third visit (adding up to four visits over two years). A study partner is required.
Non-Invasive Continuous Ultrasonic Blood Pressure Monitoring
- This research study is evaluating the use of continuous blood pressure monitor ultrasonic patch to learn more about orthostatic hypotension. The study is recruiting healthy volunteers and individuals with Hypotension, Prehypertension and Stage 1 or 2 hypertension.
Real-Time Microneedle Sensor Monitoring of Levodopa Levels in Parkinson's disease
- The project aims to develop a continuous, minimally invasive microneedle device called the "Levodopameter" which is designed to continuously measure levodopa levels in real time, with the future goals of identifying an individualized treatment regimen for Parkinson's disease patients to improve disease management.
- This study is recruiting participants with Parkinson's disease as well as healthy volunteers.
- More information about this study can be found here: https://www.clinicaltrials.gov/ct2/show/NCT04735627
For further information about this and other studies, please contact Aishwarya Niraula by email email@example.com or phone 858-246-3190.